| CAS ID: | 3230-94-2 |
| Molecular Formula: | C9H19N3O6 |
| Molecular Weight: | 265.3 g/mol |
| Monoisotopic Mass: | 265.127 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT01847651 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | May 7, 2013 | Last Verified | October 22, 2015 |
| Sponsor | Imperial College London | ||
Trial Record 2
| ClinicalTrial ID | NCT00305591 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | March 22, 2006 | Last Verified | May 29, 2015 |
| Sponsor | Imperial College London | ||
Trial Record 3
| ClinicalTrial ID | NCT01722578 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | November 7, 2012 | Last Verified | February 8, 2017 |
| Sponsor | Dayanand Medical College and Hospital | ||
Trial Record 4
| ClinicalTrial ID | NCT01440829 | Disease | Liver fibrosis |
| Phase | Phase 2,Phase 3 | Status | Completed |
| First Received | September 27, 2011 | Last Verified | December 19, 2012 |
| Sponsor | Fourth Military Medical University | ||
| PubChem: | 10220941 |
| ChEMBL: |